Rivastigmine (Rivastigmine)
Overview of Rivastigmine
Rivastigmine is a reversible non-competitive inhibitor of cholinesterases. Rivastigmine is used in alzheimer's dementia to increase brain cholinergic activity.
Indication of Rivastigmine
Rivastigmine is primarily indicated in conditions like Alzheimer's disease, Dementia, Mild to moderate dementia in alzheimer's disease.
Contraindication of Rivastigmine
Rivastigmine is contraindicated in conditions like Hypersensitivity.
Side Effects of Rivastigmine
The severe or irreversible adverse effects of Rivastigmine, which give rise to further complications include Urinary tract infection, Respiratory tract infections, Psychiatric disease.,The symptomatic adverse reactions produced by Rivastigmine are more or less tolerable and if they become severe, they can be treated symptomatically, these include Dizziness, Headache, Fatigue, Nausea, Vomiting, Anorexia, Diarrhea, Insomnia, Abdominal pain, Sweating, Confusion, Malaise, Tremor, Asthenia, SomnolenceX, Syncope, Agitation, Increased intracranial pressure.
Precautions of Rivastigmine
Rivastigmine should be used only if clearly needed during pregnancy. It should be used with caution in patients with asthma, seizure disorder, epilepsy, heart disease such as hypertension, bradycardia, recent myocardial infraction, thyroid disorders, intestinal disorders, ulcers, urinary problems or if have any allergy especially to bromides. Large dose by mouth should be avoided in condition where there may be increased absorption from the gastrointestinal tract. Use of rivastigmine is associated with weight loss and monitoring of patients weight during treatment is recommended.